$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

$foxo Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023038551 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$12.00K	$13.00K	$0.00
YoY Change
Cost Of Revenue	$12.00K	$13.00K	$40.00K
YoY Change	-69.23%	-67.5%
Gross Profit	$0.00	$0.00	-$40.00K
YoY Change	-100.0%	-100.0%
Gross Profit Margin	0.0%	0.0%
Selling, General & Admin	$4.003M	$6.332M	$2.399M
YoY Change	240.95%	163.9%	1042.59%
% of Gross Profit
Research & Development	$333.0K	$309.0K	$601.0K
YoY Change	-66.73%	-48.59%
% of Gross Profit
Depreciation & Amortization	$250.0K	$929.0K	$31.00K
YoY Change	177.78%	2896.77%
% of Gross Profit
Operating Expenses	$7.617M	$7.405M	$2.399M
YoY Change	548.77%	208.61%	1042.59%
Operating Profit	-$7.605M	-$7.392M	-$4.563M
YoY Change	547.75%	62.0%
Interest Expense	$492.0K	$225.0K	$2.022M
YoY Change	-52.77%	-88.87%	-61.18%
% of Operating Profit
Other Income/Expense, Net	$117.0K	$2.081M	-$50.00K
YoY Change	-316.67%	-4262.0%
Pretax Income	-$11.29M	-$7.639M	-$377.0K
YoY Change	8436.86%	1926.42%	-107.54%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$11.29M	-$7.639M	-$377.0K
YoY Change	8438.94%	1926.42%	-107.54%
Net Earnings / Revenue	-94108.33%	-58761.54%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.49	-$0.28	-$14.62K
COMMON SHARES
Basic Shares Outstanding	27.17M shares	29.56M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$220.0K	$2.160M	$193.3K
YoY Change	49.64%	1017.26%	-85.13%
Cash & Equivalents	$215.0K	$2.155M	$21.59M
Short-Term Investments
Other Short-Term Assets	$105.0K	$107.0K	$156.8K
YoY Change	-16.71%	-31.77%	-60.8%
Inventory	$1.300M	$1.302M
Prepaid Expenses		$2.117M
Receivables
Other Receivables
Total Short-Term Assets	$3.328M	$6.276M	$350.2K
YoY Change	1118.65%	1692.37%	-79.4%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$477.0K	$1.863M
YoY Change
Long-Term Investments			$201.3M
YoY Change			0.01%
Other Assets	$240.0K	$1.730M
YoY Change	-98.96%
Total Long-Term Assets	$719.0K	$3.597M	$201.3M
YoY Change	-99.35%	-98.21%	0.01%
TOTAL ASSETS
Total Short-Term Assets	$3.328M	$6.276M	$350.2K
Total Long-Term Assets	$719.0K	$3.597M	$201.3M
Total Assets	$4.047M	$9.873M	$201.7M
YoY Change	-96.36%	-95.1%	-0.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.021M	$2.977M	$1.987M
YoY Change	56.09%	49.86%	1886.58%
Accrued Expenses	$1.399M	$1.212M
YoY Change	89.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$200.0K
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$3.860M	$3.370M
YoY Change
Total Short-Term Liabilities	$10.16M	$8.585M	$2.192M
YoY Change	187.94%	291.73%	2091.58%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$920.0K	$1.320M	$10.16M
YoY Change	-82.32%	-87.01%	-21.25%
Total Long-Term Liabilities	$920.0K	$1.320M	$10.16M
YoY Change	-82.32%	-87.01%	-21.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.16M	$8.585M	$2.192M
Total Long-Term Liabilities	$920.0K	$1.320M	$10.16M
Total Liabilities	$11.08M	$9.903M	$12.35M
YoY Change	26.88%	-19.82%	-4.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$168.6M	-$154.9M
YoY Change	1893.76%
Common Stock	$5.000K
YoY Change	7836.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$7.030M	-$30.00K	$189.3M
YoY Change
Total Liabilities & Shareholders Equity	$4.047M	$9.873M	$201.7M
YoY Change	-96.36%	-95.1%	-0.65%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$11.29M	-$7.639M	-$377.0K
YoY Change	8438.94%	1926.42%	-107.54%
Depreciation, Depletion And Amortization	$250.0K	$929.0K	$31.00K
YoY Change	177.78%	2896.77%
Cash From Operating Activities	-$1.940M	-$3.360M	-$644.9K
YoY Change	250.34%	421.01%	486.27%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000		200.0K
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-1.940M	-$3.360M	-644.9K
Cash From Investing Activities	0.000
Cash From Financing Activities	0.000		200.0K
Net Change In Cash	-1.940M	-$3.360M	$0.00
YoY Change	4090.06%
FREE CASH FLOW
Cash From Operating Activities	-$1.940M	-$3.360M	-$644.9K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$1.940M	-$3.360M
YoY Change	6.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Depreciation Depreciation	929000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39783
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	FOXO TECHNOLOGIES INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1050265
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	729 N. Washington Ave
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Minneapolis
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55401
CY2023Q1	dei	City Area Code CityAreaCode	(612)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	562-9447
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27168069	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2155000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5515000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1302000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1313000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2117000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2686000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	595000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2676000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	107000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	114000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	6276000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12304000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1863000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2043000	usd
CY2022Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	18573000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1483000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2225000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	251000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	263000	usd
CY2023Q1	us-gaap	Assets Assets	9873000	usd
CY2022Q4	us-gaap	Assets Assets	35408000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2977000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3466000	usd
CY2023Q1	foxo	Due To Related Party Payable DueToRelatedPartyPayable	500000	usd
CY2022Q4	foxo	Due To Related Party Payable DueToRelatedPartyPayable	500000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	3368000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1409000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1212000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1045000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	528000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	493000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8585000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6913000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	311000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	311000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1730000	usd
CY2022Q4	foxo	Policy Reserves PolicyReserves	18573000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	1007000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	1173000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	9903000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	28700000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	foxo	Common Stock Value2 CommonStockValue2	3000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1483000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	foxo	Common Stock Value2 CommonStockValue2	3000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2140761	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2140761	shares
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	154837000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	153936000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-154870000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147231000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-30000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6708000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9873000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35408000	usd
CY2023Q1	us-gaap	Revenues Revenues	13000	usd
CY2022Q1	us-gaap	Revenues Revenues	40000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	309000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	601000	usd
CY2023Q1	foxo	Management Contingent Share Plans ManagementContingentSharePlans	764000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6332000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4002000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	7405000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4603000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7392000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4563000	usd
CY2022Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-7432000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	225000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	322000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-22000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-50000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-247000	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-7804000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7639000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-12367000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7639000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12367000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-25220000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12367000	usd
CY2022Q1	foxo	Lease Contributions LeaseContributions	136000	usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	251000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-37200000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6708000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7639000	usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	901000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-30000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7639000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12367000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2225000	usd
CY2023Q1	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	922000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	31000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	901000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	231000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1725000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7432000	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	135000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	94000	usd
CY2022Q1	foxo	Contributions In The Form Of Rent Payments ContributionsInTheFormOfRentPayments	136000	usd
CY2022Q1	foxo	Recognition Of Prepaid Offering Costs Upon Election Of Fair Value Option RecognitionOfPrepaidOfferingCostsUponElectionOfFairValueOption	107000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6000	usd
CY2023Q1	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	-11000	usd
CY2022Q1	us-gaap	Increase Decrease In Materials And Supplies IncreaseDecreaseInMaterialsAndSupplies	-57000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-925000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	132000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-7000	usd
CY2022Q1	foxo	Cloud Computing Arrangements CloudComputingArrangements	621000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-489000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2209000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	35000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	149000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3360000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7186000	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	39000	usd
CY2022Q1	foxo	Accrued Internal Use Software AccruedInternalUseSoftware	-519000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-558000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	22500000	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	19000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22481000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3360000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14737000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5515000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6856000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2155000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21593000	usd
CY2023Q1	us-gaap	Profit Loss From Real Estate Operations ProfitLossFromRealEstateOperations	7639000	usd
CY2023Q1	foxo	Retained Earning Appropriated RetainedEarningAppropriated	154870000	usd
CY2023Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	3360000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2155000	usd
CY2022Q1	us-gaap	Convertible Debt ConvertibleDebt	28000000	usd
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	28000000	usd
CY2023Q1	us-gaap	Other Partners Capital OtherPartnersCapital	300000000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2023Q1	foxo	Longevity Pipeline LongevityPipeline	592000	usd
CY2022Q4	foxo	Longevity Pipeline LongevityPipeline	592000	usd
CY2023Q1	foxo	Underwriting Api UnderwritingAPI	840000	usd
CY2022Q4	foxo	Underwriting Api UnderwritingAPI	840000	usd
CY2023Q1	foxo	Longevity Api LongevityAPI	717000	usd
CY2022	foxo	Longevity Api LongevityAPI	717000	usd
CY2023Q1	foxo	Less Accumulated Amortization LessAccumulatedAmortization	-286000	usd
CY2022Q4	foxo	Less Accumulated Amortization LessAccumulatedAmortization	-106000	usd
CY2023Q1	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	1863000	usd
CY2022Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	2043000	usd
CY2023Q1	foxo	Less Accumulated Amortizations LessAccumulatedAmortizations	-1483000	usd
CY2022Q4	foxo	Less Accumulated Amortizations LessAccumulatedAmortizations	-741000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss		usd
CY2022Q3	foxo	Senior Notes Percentage SeniorNotesPercentage	0.15	pure
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3458000	usd
CY2022Q3	foxo	Net Proceeds NetProceeds	2918000	usd
CY2022Q3	us-gaap	Exchange Fees ExchangeFees	540000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.15	pure
CY2023Q1	foxo	Interest Rate InterestRate	1150
CY2023Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	3368000	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	135000	usd
CY2023Q1	foxo	Amortization Of Debt AmortizationOfDebt	94	usd
CY2022Q1	foxo	Related Party Payable RelatedPartyPayable	500000	usd
CY2022Q2	foxo	Agreement Term Period AgreementTermPeriod	P12M
CY2022Q2	foxo	Exchange Fees1 ExchangeFees1	1425000	usd
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	871256	shares
CY2023Q1	us-gaap	Other Expenses OtherExpenses	2081000	usd
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	80000	shares
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.0001
CY2023Q1	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	510000000	shares
CY2023Q1	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	10000000	shares
CY2023Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q1	foxo	Warrants Description WarrantsDescription	●in whole and not in part; ●at a price of $0.01 per warrant; ●upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable; and ●if, and only if, the reported last sale price of the Company’s Class A Common Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	4237000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7639000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12367000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022Q1	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares	4646698	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	10378750	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1905853	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1905853	shares
CY2023Q1	foxo	Assumed Option Shares AssumedOptionShares	2273099	shares
CY2022Q1	foxo	Assumed Option Shares AssumedOptionShares	2965500	shares
CY2023Q1	foxo	Total Antidilutive Shares TotalAntidilutiveShares	14557702	shares
CY2022Q1	foxo	Total Antidilutive Shares TotalAntidilutiveShares	24088202	shares
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	311000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	311000	usd
CY2023Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	5002000	usd
CY2023Q1	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	51000	usd
CY2023Q1	us-gaap	Ceded Premiums Earned CededPremiumsEarned	251000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	4751000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization		usd
CY2023Q1	foxo	Nonredeemable Preferred Stock NonredeemablePreferredStock		usd
CY2022Q4	foxo	Nonredeemable Preferred Stock NonredeemablePreferredStock		usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	13000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	40000	usd
CY2023Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	937000	usd
CY2022Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	1307000	usd
CY2023Q1	foxo	Corporate And Other CorporateAndOther	-6477000	usd
CY2022Q1	foxo	Corporate And Other CorporateAndOther	-10738000	usd
CY2023Q1	foxo	Interest Expense Earnings InterestExpenseEarnings	-225000	usd
CY2022Q1	foxo	Interest Expense Earnings InterestExpenseEarnings	-322000	usd
CY2023Q1	us-gaap	Revenues Revenues	13000	usd
CY2022Q1	us-gaap	Revenues Revenues	40000	usd
CY2023Q1	us-gaap	Distributed Earnings DistributedEarnings	7639000	usd
CY2022Q1	us-gaap	Distributed Earnings DistributedEarnings	12367000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	2626000	usd
CY2023Q1	foxo	Change In Fair Value Of Convertible Debentures ChangeInFairValueOfConvertibleDebentures	929000	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	231000	usd
CY2022Q1	foxo	Changes In Fair Value Of Convertible Debentures Warrant Liability And Forward Purchase Derivative ChangesInFairValueOfConvertibleDebenturesWarrantLiabilityAndForwardPurchaseDerivative	31000	usd
CY2022Q1	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	7432000	usd
CY2023Q1	foxo	Purchase Units PurchaseUnits	10000	shares
CY2023Q1	foxo	Supply Commitment Remaining SupplyCommitmentRemaining	3000	shares
CY2023Q1	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	92000	usd
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	146000	usd
CY2023Q1	foxo	Primarily Related To An Advisor Fee PrimarilyRelatedToAnAdvisorFee	238000	usd
CY2023Q1	foxo	Outstanding Balance Percentage OutstandingBalancePercentage	0.125	pure
CY2023Q1	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	6207000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	696000	usd
CY2023Q1	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	879000	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	9130000	usd
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.0125	pure
CY2023Q1	foxo	Original Principal Amount OriginalPrincipalAmount	1
CY2023Q1	us-gaap	Shares Issued SharesIssued	4321875	shares
CY2023Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables		usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q1	foxo	Policy Reserves PolicyReserves		usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2023Q1	foxo	Contributions In The Form Of Rent Payments ContributionsInTheFormOfRentPayments		usd
CY2023Q1	foxo	Recognition Of Prepaid Offering Costs Upon Election Of Fair Value Option RecognitionOfPrepaidOfferingCostsUponElectionOfFairValueOption		usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2023Q1	foxo	Cloud Computing Arrangements CloudComputingArrangements		usd
CY2023Q1	foxo	Accrued Internal Use Software AccruedInternalUseSoftware		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q1	us-gaap	Treasury Stock Preferred Shares TreasuryStockPreferredShares		shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued		shares
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001812360

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
foxo-20230331_pre.xml	Edgar Link	unprocessable
foxo-20230331_lab.xml	Edgar Link	unprocessable
0001213900-23-038551-index-headers.html	Edgar Link	pending
0001213900-23-038551-index.html	Edgar Link	pending
0001213900-23-038551.txt	Edgar Link	pending
0001213900-23-038551-xbrl.zip	Edgar Link	pending
f10q0323ex31-1_foxotech.htm	Edgar Link	pending
f10q0323ex31-2_foxotech.htm	Edgar Link	pending
f10q0323ex32-1_foxotech.htm	Edgar Link	pending
f10q0323_foxotech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
foxo-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
foxo-20230331_cal.xml	Edgar Link	unprocessable
foxo-20230331_def.xml	Edgar Link	unprocessable
f10q0323_foxotech_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo

2023 Q2 Form 10-Q Financial Statement

#000121390023038551 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO FOXO TECHNOLOGIES INC. Stock $foxo

2023 Q2 Form 10-Q Financial Statement

#000121390023038551 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOXO
FOXO TECHNOLOGIES INC. Stock $foxo